Related Experiment Video
Updated: Jan 14, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Treatment of a Pediatric Arterial Ischemic Stroke With Tenecteplase
Mostafa Alsabbagh1, Maham Alvi2, Aryaan Khan3
1Internal Medicine, Summa Health, Akron, USA.
Insights
Pediatric stroke is rare but serious. Tenecteplase, a thrombolytic, was safely and successfully used to treat a 16-year-old's ischemic stroke, offering a potential new treatment option.
Area of Science:
- Neurology
- Pediatric Medicine
- Vascular Neurology
Background:
- Stroke in children is uncommon but has significant long-term consequences.
- Thrombolytic therapy is standard for adult ischemic stroke but lacks established efficacy and safety data in pediatric populations.
- Tenecteplase, a newer thrombolytic, has limited documented use in pediatric ischemic stroke.
Abstract:
Although rare, stroke in children is a worrisome event that can have a profound impact on their development and future health outcomes as adults. While the use of the thrombolytics has become a mainstay of treatment for ischemic stroke in adults at comprehensive stroke centers, neither the efficacy nor the safety of thrombolytics for stroke in children has been established. This is, in part, due to the rarity of the pathology and difficulty in recruitment for clinical studies. Additionally, the more recently adopted thrombolytic, tenecteplase, has even fewer known cases of use in the treatment of ischemic stroke in children. We present a case of a 16-year-old male who presented with an ischemic stroke affecting the middle cerebral artery territory, which was promptly, safely, and successfully treated with tenecteplase.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care

